Plasma Sphingolipids in Acute Pancreatitis

Area of Science:

• Biochemistry
• Gastroenterology
• Molecular Medicine

Background:

• Acute pancreatitis (AP) is a common gastrointestinal disease with significant mortality, especially in severe cases.
• Current treatments focus on supportive care, lacking direct molecular interventions.
• The sphingolipid signaling pathway is implicated in pancreatic inflammation.

Purpose of the Study:

• To investigate the role of plasma sphingolipids in the pathogenesis of acute pancreatitis.
• To identify potential molecular markers for predicting AP severity.

Main Methods:

• Analysis of plasma sphingolipid profiles in 44 AP patients (mild, moderate, severe).
• Sample collection at 1, 3, and 7 days post-admission.
• Quantification of sphingolipids, including ceramide and sphingosine-1-phosphate (S1P).

Main Results:

• Significant alterations in plasma sphingolipid profiles were observed over the course of AP.
• Inhibition of de novo ceramide synthesis occurred in mild and moderate AP.
• Elevated S1P levels were noted in mild AP, while severe AP showed a marked reduction in S1P early in the disease course.

Conclusions:

• Plasma sphingolipid profiles dynamically change during acute pancreatitis.
• Sphingosine-1-phosphate (S1P) levels show distinct patterns in mild versus severe AP.
• Plasma S1P holds promise as a prognostic biomarker for acute pancreatitis severity.